Gain Therapeutics, Inc.GANXNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank50
3Y CAGR-32.2%
5Y CAGR+79.0%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
-32.2%/yr
Annual compound
5Y CAGR
+79.0%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
18.4x
Strong expansion
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
2024$12.12M-34.9%
2023$18.61M-22.8%
2022$24.10M-38.2%
2021$38.99M+305.9%
2020$9.60M+1354.6%
2019$660286.00-18.6%
2018$811634.00-